We are live on ! Find out more
ZURA icon

Zura Bio

35 hedge funds and large institutions have $87.4M invested in Zura Bio in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 3

9% more capital invested

Capital invested by funds: $80.5M → $87.4M (+$7M)

6% more funds holding

Funds holding: 3335 (+2)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

Holders
35
Holders Change
+2
Holders Change %
+6.06%
% of All Funds
0.56%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
3
Reduced
6
Closed
3
Calls
$167K
Puts
Net Calls
+$167K
Net Calls Change
+$3K

ZURA Hedge Fund Activity: Q4 2022 in Review

35 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Zura Bio (ZURA) for Q4 2022, worth a combined $87.4M — up 8.7% from $80.5M a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new ZURA positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 6 trimmed.

The largest buyer was Glazer Capital LLC, adding an estimated $4.29M. The largest seller was Millennium Management, cutting an estimated $3.05M.

  • 35 institutional investors held Zura Bio (ZURA) as of Q4 2022, up from 33 in Q3 2022.
  • Funds reported $87.4M of Zura Bio stock for Q4 2022, up 8.7% quarter-over-quarter.
  • 5 funds opened new Zura Bio positions in Q4 2022 and 3 closed out, a net change of +2 holders.
  • The largest Zura Bio buyer in Q4 2022 was Glazer Capital LLC, an estimated $4.29M added.
  • The largest Zura Bio seller in Q4 2022 was Millennium Management, an estimated $3.05M sold.

Based on aggregated 13F filings for Q4 2022.